advertisement
Dunn H 29
Showing records 1 to 25 | Display all abstracts from Dunn H121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Arnould L
British Journal of Ophthalmology 2024; 108: 1672-1678
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Tan JCK
Ophthalmology. Glaucoma 2024; 7: 539-550
119369 Glaucoma severity at first presentation to an ophthalmologist and risk factors for late presentation in rural Australia: the S1P study
Al-Timimi Z
Clinical and Experimental Optometry 2024; 0: 1-8
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Balsat E
British Journal of Ophthalmology 2024; 108: 1672-1678
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Hashimoto Y
Ophthalmology. Glaucoma 2024; 7: 539-550
119369 Glaucoma severity at first presentation to an ophthalmologist and risk factors for late presentation in rural Australia: the S1P study
Campbell A; Keay L; Keay L
Clinical and Experimental Optometry 2024; 0: 1-8
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Hashimoto Y
British Journal of Ophthalmology 2024; 108: 1672-1678
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Gabrielle PH
Ophthalmology. Glaucoma 2024; 7: 539-550
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
White A
British Journal of Ophthalmology 2024; 108: 1672-1678
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Garcher CC
Ophthalmology. Glaucoma 2024; 7: 539-550
119369 Glaucoma severity at first presentation to an ophthalmologist and risk factors for late presentation in rural Australia: the S1P study
Popovic G; Mulligan N
Clinical and Experimental Optometry 2024; 0: 1-8
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Kong G
British Journal of Ophthalmology 2024; 108: 1672-1678
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
White A
Ophthalmology. Glaucoma 2024; 7: 539-550
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Dunn H
British Journal of Ophthalmology 2024; 108: 1672-1678
119369 Glaucoma severity at first presentation to an ophthalmologist and risk factors for late presentation in rural Australia: the S1P study
Thompson C
Clinical and Experimental Optometry 2024; 0: 1-8
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Dunn H; Dunn H
Ophthalmology. Glaucoma 2024; 7: 539-550
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Dunn H
British Journal of Ophthalmology 2024; 108: 1672-1678
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Walland M
Ophthalmology. Glaucoma 2024; 7: 539-550
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Fan L
British Journal of Ophthalmology 2024; 108: 1672-1678
119369 Glaucoma severity at first presentation to an ophthalmologist and risk factors for late presentation in rural Australia: the S1P study
Game J
Clinical and Experimental Optometry 2024; 0: 1-8
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Wechsler D
Ophthalmology. Glaucoma 2024; 7: 539-550
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Gabrielle PH
British Journal of Ophthalmology 2024; 108: 1672-1678
119369 Glaucoma severity at first presentation to an ophthalmologist and risk factors for late presentation in rural Australia: the S1P study
Hopley C; Rossiter-Thornton M
Clinical and Experimental Optometry 2024; 0: 1-8
121222 Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry
Bron AM
British Journal of Ophthalmology 2024; 108: 1672-1678
121046 Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma
Arnould L; Lawlor M
Ophthalmology. Glaucoma 2024; 7: 539-550
